A recent study by the British Medical Journal (BMJ) claims that a substantial number of people across the world might not be able to get vaccinated against COVID-19 until 2022.
The study suggests that the challenges faced in developing vaccines for COVID-19 may be of a similar concern as nations turn to the next step of combatting the disease: vaccination distribution.
For the study, researchers evaluated the pre-orders of vaccines used against COVID-19.
Out of the total number of pre-orders, a little over half of the doses ordered will be distributed first to high-income nations, which is representative of about 14 percent of the global population.
From the BMJ article: “This study provides an overview of how high-income countries have secured future supplies of covid-19 vaccines but that access for the rest of the world is uncertain.”
It continues by stating, “Governments and manufacturers might provide much needed assurances for equitable allocation of covid-19 vaccines through greater transparency and accountability over these arrangements.”
The findings were derived from data supplied by the World Health Organization, the US Securities and Exchange Commission, organizational and government press releases, and news media reports.
